Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29129002 | 0.99 | TYR (0.69) | TYR | |
| SCHEMBL467724 | 0.99 | TYR (0.69) | TYR | |
| SCHEMBL28068283 | 0.99 | TYR (0.69) | TYR | |
| SCHEMBL24198671 | 0.99 | TYR (0.69) | TYR | |
| SCHEMBL2035138 | 0.95 | TYR (0.64) | TYR | |
| SCHEMBL2035140 | 0.95 | TYR (0.64) | TYR | |
| SCHEMBL6842195 | 0.87 | TYR (0.65) | TYR | |
| SCHEMBL6842196 | 0.87 | TYR (0.65) | TYR | |
| SCHEMBL8656793 | 0.87 | TYR (0.58) | TYR | |
| SCHEMBL9014308 | 0.87 | TYR (0.58) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11252960-B2 | Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| US-11224221-B2 | — | — | 2022-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11252960-B2 | Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same | DBI, BCAT1, TBCA | TYR 445/4885 |
| US-11224221-B2 | — | TBCA, SPOUT1, BPGM | TYR 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.